Cordlife Group (SGX:P8A) Cyclically Adjusted Revenue per Share: S$0.28 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:P8A Cordlife Group Ltd SGX:P8A
35 GF Score
Price S$0.13
GF Value S$0.14
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cordlife Group Cyclically Adjusted Revenue per Share?

Cordlife Group SGX:P8A 35 Cyclically Adjusted Revenue per Share is S$0.28 as of Jun. 2026. GuruFocus rates SGX:P8A with a GF Score™ of 35/100 and a GF Value™ of S$0.14 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cordlife Group's adjusted revenue per share for the three months ended in Jun. 2026 was S$0.032. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is S$0.28 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-08), Cordlife Group's current stock price is S$0.132. Cordlife Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was S$0.28. Cordlife Group's Cyclically Adjusted PS Ratio of today is 0.47.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cordlife Group was 1.11. The lowest was 0.43. And the median was 0.55.


Cordlife Group  (SGX:P8A) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cordlife Group's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.132/0.28
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cordlife Group was 1.11. The lowest was 0.43. And the median was 0.55.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cordlife Group Cyclically Adjusted Revenue per Share Related Terms


Cordlife Group Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Cordlife Group's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cordlife Group Cyclically Adjusted Revenue per Share Chart

Cordlife Group Annual Data
Trend Jun15 Jun16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.28 0.28

Cordlife Group Quarterly Data
Jun19 Sep19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.28 0.28 0.28 0.28

SGX:P8A vs TMO, DHR, NTRA: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Cordlife Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cordlife Group Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cordlife Group's Cyclically Adjusted PS Ratio falls into.


SGX:P8A
35GF Score
Cordlife Group Ltd SGX:P8A
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cordlife Group Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cordlife Group's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.032/333.9520*333.9520
=0.032

Current CPI (Jun. 2026) = 333.9520.

Cordlife Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.044 236.293 0.062
201406 0.052 238.343 0.073
201409 0.051 238.031 0.072
201412 0.055 234.812 0.078
201503 0.055 236.119 0.078
201506 0.061 238.638 0.085
201509 0.056 237.945 0.079
201512 0.056 236.525 0.079
201603 0.058 238.132 0.081
201606 0.060 241.018 0.083
201609 0.056 241.428 0.077
201612 0.059 241.432 0.082
201703 0.055 243.801 0.075
201706 0.061 244.955 0.083
201709 0.065 246.819 0.088
201712 0.065 246.524 0.088
201803 0.069 249.554 0.092
201806 0.069 251.989 0.091
201809 0.066 252.439 0.087
201903 0.065 254.202 0.085
201906 0.065 256.143 0.085
201909 0.061 256.759 0.079
201912 0.064 256.974 0.083
202006 0.000 257.797 0.000
202012 0.000 260.474 0.000
202106 0.000 271.696 0.000
202112 0.000 278.802 0.000
202206 0.000 296.311 0.000
202212 0.000 296.797 0.000
202306 0.000 305.109 0.000
202312 0.000 306.746 0.000
202406 0.000 314.175 0.000
202409 0.039 315.301 0.041
202412 0.033 315.605 0.035
202503 0.037 319.799 0.039
202506 0.037 322.561 0.038
202509 0.040 324.800 0.041
202512 0.037 324.054 0.038
202603 0.035 330.213 0.035
202606 0.032 333.952 0.032

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of S$0.28 mean?
Cordlife Group (SGX:P8A) has a Cyclically Adjusted Revenue per Share of S$0.28 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cordlife Group and its competitors.
Is Cordlife Group's Cyclically Adjusted Revenue per Share too high?
Cordlife Group's current Cyclically Adjusted Revenue per Share is S$0.28. Overall, Cordlife Group has a GF Score™ of 35/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cordlife Group's Cyclically Adjusted Revenue per Share compare to TMO and DHR?
Cordlife Group's Cyclically Adjusted Revenue per Share of S$0.28 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cordlife Group and its competitors. Cordlife Group's current Cyclically Adjusted Revenue per Share is S$0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cordlife Group stock overvalued right now?
Based on GuruFocus' analysis, Cordlife Group (SGX:P8A) is currently considered Fairly Valued. The stock's GF Value™ is S$0.14, compared to a current price of S$0.13 — trading 5.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is S$0.28. Cordlife Group's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Cordlife Group (SGX:P8A), the current Cyclically Adjusted Revenue per Share is S$0.28 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cordlife Group (SGX:P8A) Overvalued in 2026?

Based on GuruFocus' analysis, Cordlife Group stock appears to be undervalued. The current stock price of S$0.13 is trading 5.7% below its estimated GF Value™ of S$0.14. GuruFocus considers Cordlife Group to be Fairly Valued.

Key valuation signals for SGX:P8A:

  • Cyclically Adjusted Revenue per Share: S$0.28
  • GF Value™: S$0.14 vs. price of S$0.13 (5.7% below fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the SGX:P8A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cordlife Group Business Description

Other Exchanges CLIFF:USA
Address 1 Kim Seng Promenade, No. 15-01, Great World City East, Singapore, SGP, 237994
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Along with its subsidiaries, the company is engaged in the provision of diagnostics and cord blood banking services, which involve the processing and storage of cord blood stem cells. The group has two reportable segments as follows: the Banking segment, which derives maximum revenue, comprises the collection, processing, and banking of biological materials; and the Diagnostics segment, which comprises diagnostics testing services. Geographically, the group generates maximum revenue from Hong Kong, and the rest from the Philippines, India, Malaysia, Singapore, and other regions.
35GF Score

Get the complete analysis for SGX:P8A

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.13
Price
S$0.14
GF Value